0000950123-10-049823 Sample Contracts
RESTATED 8% CONVERTIBLE DEBENTURE DUE DECEMBER 31, 2011Convertible Security Agreement • May 14th, 2010 • Lifevantage Corp • Pharmaceutical preparations • California
THIS RESTATED 8% CONVERTIBLE DEBENTURE is a duly authorized and validly issued 8% Convertible Debenture of LifeVantage Corporation, a Colorado corporation (the “Company”), having its principal place of business at 11545 West Bernardo Court, Suite 301, San Diego, California 92127, designated as its 8% Convertible Debenture due December 31, 2011 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2010 • Lifevantage Corp • Pharmaceutical preparations • California
This Amended and Restated Securities Purchase Agreement (this “Agreement”) dated as of February 26, 2010 is entered into by and among LifeVantage Corporation, a Colorado corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2010 • Lifevantage Corp • Pharmaceutical preparations • California
This Amended and Restated Securities Purchase Agreement (this “Agreement”) dated as of January 20, 2010 is entered into by and among LifeVantage Corporation, a Colorado corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2010 • Lifevantage Corp • Pharmaceutical preparations • California
This Amended and Restated Securities Purchase Agreement (this “Agreement”) dated as of December 31, 2009 is entered into by and among LifeVantage Corporation, a Colorado corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).